# Cisco Systems, Inc.: financial statements, quarterly CSCO · Nasdaq · CIK 858877 · [Technology](/sectors/technology.md) · fiscal year ends Jul 31 Pages: [Overview](/companies/csco.md) · [Financials](/companies/csco/financials.md) · [Filings](/companies/csco/filings.md) · [Insiders](/companies/csco/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/csco/financials.md?period=annual). ## Income statement | Line item | Unit | Q1 FY2024 (2023-10-28) | Q2 FY2024 (2024-01-27) | Q3 FY2024 (2024-04-27) | Q4 FY2024 (2024-07-27) | Q1 FY2025 (2024-10-26) | Q2 FY2025 (2025-01-25) | Q3 FY2025 (2025-04-26) | Q4 FY2025 (2025-07-26) | Q1 FY2026 (2025-10-25) | Q2 FY2026 (2026-01-24) | Q3 FY2026 (2026-04-25) | Q4 FY2026 (2026-07-25) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [14.7](/filings/0000858877-24-000030.md) | [12.8](/filings/0000858877-25-000007.md) | [12.7](/filings/0000858877-25-000033.md) | [13.6 d](/filings/0000858877-26-000132.md) | [13.8](/filings/0000858877-25-000171.md) | [14.0](/filings/0000858877-26-000021.md) | [14.1](/filings/0000858877-26-000078.md) | [14.7 d](/filings/0000858877-26-000132.md) | [14.9](/filings/0000858877-25-000171.md) | [15.3](/filings/0000858877-26-000021.md) | [15.8](/filings/0000858877-26-000078.md) | [17.3 d](/filings/0000858877-26-000132.md) | | Cost of revenue | $bn | [5.1](/filings/0000858877-24-000030.md) | [4.6](/filings/0000858877-25-000007.md) | [4.4](/filings/0000858877-25-000033.md) | [4.9 d](/filings/0000858877-26-000132.md) | [4.7](/filings/0000858877-25-000171.md) | [4.9](/filings/0000858877-26-000021.md) | [4.9](/filings/0000858877-26-000078.md) | [5.4 d](/filings/0000858877-26-000132.md) | [5.1](/filings/0000858877-25-000171.md) | [5.4](/filings/0000858877-26-000021.md) | [5.8](/filings/0000858877-26-000078.md) | [6.2 d](/filings/0000858877-26-000132.md) | | Gross profit | $bn | [9.6](/filings/0000858877-24-000030.md) | [8.2](/filings/0000858877-25-000007.md) | [8.3](/filings/0000858877-25-000033.md) | [8.8 d](/filings/0000858877-26-000132.md) | [9.1](/filings/0000858877-25-000171.md) | [9.1](/filings/0000858877-26-000021.md) | [9.3](/filings/0000858877-26-000078.md) | [9.3 d](/filings/0000858877-26-000132.md) | [9.7](/filings/0000858877-25-000171.md) | [10.0](/filings/0000858877-26-000021.md) | [10.1](/filings/0000858877-26-000078.md) | [11.1 d](/filings/0000858877-26-000132.md) | | Research and development | $bn | [1.9](/filings/0000858877-24-000030.md) | [1.9](/filings/0000858877-25-000007.md) | [1.9](/filings/0000858877-25-000033.md) | [2.2 d](/filings/0000858877-26-000132.md) | [2.3](/filings/0000858877-25-000171.md) | [2.3](/filings/0000858877-26-000021.md) | [2.3](/filings/0000858877-26-000078.md) | [2.4 d](/filings/0000858877-26-000132.md) | [2.4](/filings/0000858877-25-000171.md) | [2.4](/filings/0000858877-26-000021.md) | [2.4](/filings/0000858877-26-000078.md) | [2.4 d](/filings/0000858877-26-000132.md) | | Operating income | $bn | [4.3](/filings/0000858877-24-000030.md) | [3.1](/filings/0000858877-25-000007.md) | [2.2](/filings/0000858877-25-000033.md) | [2.6 d](/filings/0000858877-26-000132.md) | [2.4](/filings/0000858877-25-000171.md) | [3.1](/filings/0000858877-26-000021.md) | [3.2](/filings/0000858877-26-000078.md) | [3.1 d](/filings/0000858877-26-000132.md) | [3.4](/filings/0000858877-25-000171.md) | [3.8](/filings/0000858877-26-000021.md) | [4.0](/filings/0000858877-26-000078.md) | [4.3 d](/filings/0000858877-26-000132.md) | | Interest expense | $bn | [0.1](/filings/0000858877-23-000031.md) | [0.1](/filings/0000858877-24-000003.md) | [0.4](/filings/0000858877-24-000007.md) | [0.4 d](/filings/0000858877-26-000132.md) | [0.4](/filings/0000858877-25-000171.md) | [0.4](/filings/0000858877-26-000021.md) | [0.4](/filings/0000858877-26-000078.md) | [0.4 d](/filings/0000858877-26-000132.md) | [0.4](/filings/0000858877-25-000171.md) | [0.4](/filings/0000858877-26-000021.md) | [0.4](/filings/0000858877-26-000078.md) | [0.4 d](/filings/0000858877-26-000132.md) | | Income tax | $bn | [0.8](/filings/0000858877-24-000030.md) | [0.5](/filings/0000858877-25-000007.md) | [0.3](/filings/0000858877-25-000033.md) | [0.2 d](/filings/0000858877-26-000132.md) | [(0.4)](/filings/0000858877-25-000171.md) | [0.5](/filings/0000858877-26-000021.md) | [0.5](/filings/0000858877-26-000078.md) | [0.4 d](/filings/0000858877-26-000132.md) | [0.5](/filings/0000858877-25-000171.md) | [0.5](/filings/0000858877-26-000021.md) | [0.7](/filings/0000858877-26-000078.md) | [1.1 d](/filings/0000858877-26-000132.md) | | Net income | $bn | [3.6](/filings/0000858877-24-000030.md) | [2.6](/filings/0000858877-25-000007.md) | [1.9](/filings/0000858877-25-000033.md) | [2.2 d](/filings/0000858877-26-000132.md) | [2.7](/filings/0000858877-25-000171.md) | [2.4](/filings/0000858877-26-000021.md) | [2.5](/filings/0000858877-26-000078.md) | [2.6 d](/filings/0000858877-26-000132.md) | [2.9](/filings/0000858877-25-000171.md) | [3.2](/filings/0000858877-26-000021.md) | [3.4](/filings/0000858877-26-000078.md) | [3.9 d](/filings/0000858877-26-000132.md) | | Diluted EPS | $ per share | [0.89](/filings/0000858877-24-000030.md) | [0.65](/filings/0000858877-25-000007.md) | [0.46](/filings/0000858877-25-000033.md) | not reported | [0.68](/filings/0000858877-25-000171.md) | [0.61](/filings/0000858877-26-000021.md) | [0.62](/filings/0000858877-26-000078.md) | not reported | [0.72](/filings/0000858877-25-000171.md) | [0.80](/filings/0000858877-26-000021.md) | [0.85](/filings/0000858877-26-000078.md) | not reported | | Basic EPS | $ per share | [0.90](/filings/0000858877-24-000030.md) | [0.65](/filings/0000858877-25-000007.md) | [0.47](/filings/0000858877-25-000033.md) | not reported | [0.68](/filings/0000858877-25-000171.md) | [0.61](/filings/0000858877-26-000021.md) | [0.63](/filings/0000858877-26-000078.md) | not reported | [0.72](/filings/0000858877-25-000171.md) | [0.80](/filings/0000858877-26-000021.md) | [0.85](/filings/0000858877-26-000078.md) | not reported | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q1 FY2024 (2023-10-28) | Q2 FY2024 (2024-01-27) | Q3 FY2024 (2024-04-27) | FY2024 (2024-07-27) | Q1 FY2025 (2024-10-26) | Q2 FY2025 (2025-01-25) | Q3 FY2025 (2025-04-26) | FY2025 (2025-07-26) | Q1 FY2026 (2025-10-25) | Q2 FY2026 (2026-01-24) | Q3 FY2026 (2026-04-25) | FY2026 (2026-07-25) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [9.6](/filings/0000858877-23-000031.md) | [13.7](/filings/0000858877-24-000003.md) | [8.9](/filings/0000858877-24-000007.md) | [7.5](/filings/0000858877-25-000111.md) | [9.1](/filings/0000858877-24-000030.md) | [8.6](/filings/0000858877-25-000007.md) | [8.2](/filings/0000858877-25-000033.md) | [8.3](/filings/0000858877-26-000132.md) | [8.4](/filings/0000858877-25-000171.md) | [7.5](/filings/0000858877-26-000021.md) | [7.1](/filings/0000858877-26-000078.md) | [7.2](/filings/0000858877-26-000132.md) | | Current assets | $bn | [39.7](/filings/0000858877-23-000031.md) | [42.1](/filings/0000858877-24-000003.md) | [35.9](/filings/0000858877-24-000007.md) | [36.9](/filings/0000858877-25-000111.md) | [35.8](/filings/0000858877-24-000030.md) | [34.7](/filings/0000858877-25-000007.md) | [32.8](/filings/0000858877-25-000033.md) | [35.0](/filings/0000858877-26-000132.md) | [32.9](/filings/0000858877-25-000171.md) | [35.1](/filings/0000858877-26-000021.md) | [36.6](/filings/0000858877-26-000078.md) | [38.7](/filings/0000858877-26-000132.md) | | Total assets | $bn | [98.8](/filings/0000858877-23-000031.md) | [101](/filings/0000858877-24-000003.md) | [123](/filings/0000858877-24-000007.md) | [124](/filings/0000858877-25-000111.md) | [123](/filings/0000858877-24-000030.md) | [121](/filings/0000858877-25-000007.md) | [120](/filings/0000858877-25-000033.md) | [122](/filings/0000858877-26-000132.md) | [121](/filings/0000858877-25-000171.md) | [123](/filings/0000858877-26-000021.md) | [126](/filings/0000858877-26-000078.md) | [130](/filings/0000858877-26-000132.md) | | Current liabilities | $bn | [27.0](/filings/0000858877-23-000031.md) | [30.9](/filings/0000858877-24-000003.md) | [40.1](/filings/0000858877-24-000007.md) | [40.6](/filings/0000858877-25-000111.md) | [40.5](/filings/0000858877-24-000030.md) | [40.0](/filings/0000858877-25-000007.md) | [34.5](/filings/0000858877-25-000033.md) | [35.1](/filings/0000858877-26-000132.md) | [35.5](/filings/0000858877-25-000171.md) | [36.8](/filings/0000858877-26-000021.md) | [39.5](/filings/0000858877-26-000078.md) | [41.5](/filings/0000858877-26-000132.md) | | Total liabilities | $bn | [53.6](/filings/0000858877-23-000031.md) | [54.9](/filings/0000858877-24-000003.md) | [77.2](/filings/0000858877-24-000007.md) | [79.0](/filings/0000858877-25-000111.md) | [78.1](/filings/0000858877-24-000030.md) | [75.8](/filings/0000858877-25-000007.md) | [73.8](/filings/0000858877-25-000033.md) | [75.4](/filings/0000858877-26-000132.md) | [74.2](/filings/0000858877-25-000171.md) | [75.6](/filings/0000858877-26-000021.md) | [76.7](/filings/0000858877-26-000078.md) | [79.4](/filings/0000858877-26-000132.md) | | Long-term debt | $bn | [6.7](/filings/0000858877-23-000031.md) | [6.7](/filings/0000858877-24-000003.md) | [20.1](/filings/0000858877-24-000007.md) | [19.6](/filings/0000858877-25-000111.md) | [19.6](/filings/0000858877-24-000030.md) | [19.6](/filings/0000858877-25-000007.md) | [22.9](/filings/0000858877-25-000033.md) | [22.9](/filings/0000858877-26-000132.md) | [21.4](/filings/0000858877-25-000171.md) | [21.4](/filings/0000858877-26-000021.md) | [19.4](/filings/0000858877-26-000078.md) | [19.4](/filings/0000858877-26-000132.md) | | Current portion of debt | $bn | [1.0](/filings/0000858877-23-000031.md) | [1.0](/filings/0000858877-24-000003.md) | [0.0](/filings/0000858877-24-000007.md) | [0.5](/filings/0000858877-25-000111.md) | [0.5](/filings/0000858877-24-000030.md) | [0.5](/filings/0000858877-25-000007.md) | [2.2](/filings/0000858877-25-000033.md) | [1.8](/filings/0000858877-26-000132.md) | [3.2](/filings/0000858877-25-000171.md) | [3.3](/filings/0000858877-26-000021.md) | [3.5](/filings/0000858877-26-000078.md) | [3.5](/filings/0000858877-26-000132.md) | | Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $bn | [45.2](/filings/0000858877-25-000007.md) | [46.3](/filings/0000858877-25-000033.md) | [45.8](/filings/0000858877-25-000033.md) | [45.5](/filings/0000858877-26-000132.md) | [45.3](/filings/0000858877-26-000021.md) | [45.5](/filings/0000858877-26-000078.md) | [45.9](/filings/0000858877-26-000078.md) | [46.8](/filings/0000858877-26-000132.md) | [46.9](/filings/0000858877-26-000021.md) | [47.7](/filings/0000858877-26-000078.md) | [48.9](/filings/0000858877-26-000078.md) | [50.3](/filings/0000858877-26-000132.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q1 FY2024 (2023-10-28) | Q2 FY2024 (2024-01-27) | Q3 FY2024 (2024-04-27) | Q4 FY2024 (2024-07-27) | Q1 FY2025 (2024-10-26) | Q2 FY2025 (2025-01-25) | Q3 FY2025 (2025-04-26) | Q4 FY2025 (2025-07-26) | Q1 FY2026 (2025-10-25) | Q2 FY2026 (2026-01-24) | Q3 FY2026 (2026-04-25) | Q4 FY2026 (2026-07-25) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [2,371](/filings/0000858877-24-000030.md) | [808 d](/filings/0000858877-25-000007.md) | [3,971 d](/filings/0000858877-25-000033.md) | [3,730 d](/filings/0000858877-26-000132.md) | [3,661](/filings/0000858877-25-000171.md) | [2,241 d](/filings/0000858877-26-000021.md) | [4,057 d](/filings/0000858877-26-000078.md) | [4,234 d](/filings/0000858877-26-000132.md) | [3,212](/filings/0000858877-25-000171.md) | [1,822 d](/filings/0000858877-26-000021.md) | [3,757 d](/filings/0000858877-26-000078.md) | [5,386 d](/filings/0000858877-26-000132.md) | | Capital expenditure | $m | [134](/filings/0000858877-24-000030.md) | [170 d](/filings/0000858877-25-000007.md) | [168 d](/filings/0000858877-25-000033.md) | [198 d](/filings/0000858877-26-000132.md) | [217](/filings/0000858877-25-000171.md) | [210 d](/filings/0000858877-26-000021.md) | [261 d](/filings/0000858877-26-000078.md) | [217 d](/filings/0000858877-26-000132.md) | [323](/filings/0000858877-25-000171.md) | [283 d](/filings/0000858877-26-000021.md) | [414 d](/filings/0000858877-26-000078.md) | [390 d](/filings/0000858877-26-000132.md) | | Dividends paid | $m | [1,580](/filings/0000858877-24-000030.md) | [1,583 d](/filings/0000858877-25-000007.md) | [1,615 d](/filings/0000858877-25-000033.md) | [1,606 d](/filings/0000858877-26-000132.md) | [1,592](/filings/0000858877-25-000171.md) | [1,593 d](/filings/0000858877-26-000021.md) | [1,627 d](/filings/0000858877-26-000078.md) | [1,625 d](/filings/0000858877-26-000132.md) | [1,617](/filings/0000858877-25-000171.md) | [1,617 d](/filings/0000858877-26-000021.md) | [1,660 d](/filings/0000858877-26-000078.md) | [1,659 d](/filings/0000858877-26-000132.md) | | Share repurchases | $m | [1,300](/filings/0000858877-24-000030.md) | [1,204 d](/filings/0000858877-25-000007.md) | [1,268 d](/filings/0000858877-25-000033.md) | [2,015 d](/filings/0000858877-26-000132.md) | [2,003](/filings/0000858877-25-000171.md) | [1,240 d](/filings/0000858877-26-000021.md) | [1,505 d](/filings/0000858877-26-000078.md) | [1,252 d](/filings/0000858877-26-000132.md) | [1,992](/filings/0000858877-25-000171.md) | [1,363 d](/filings/0000858877-26-000021.md) | [1,250 d](/filings/0000858877-26-000078.md) | [1,501 d](/filings/0000858877-26-000132.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q1 FY2023 (2022-10-29) | Q2 FY2023 (2023-01-28) | Q3 FY2023 (2023-04-29) | Q1 FY2024 (2023-10-28) | Q2 FY2024 (2024-01-27) | Q3 FY2024 (2024-04-27) | Q1 FY2025 (2024-10-26) | Q2 FY2025 (2025-01-25) | Q3 FY2025 (2025-04-26) | Q1 FY2026 (2025-10-25) | Q2 FY2026 (2026-01-24) | Q3 FY2026 (2026-04-25) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [4,116](/filings/0000858877-23-000031.md) | [4,116](/filings/0000858877-24-000003.md) | [4,110](/filings/0000858877-24-000007.md) | [4,087](/filings/0000858877-24-000030.md) | [4,073](/filings/0000858877-25-000007.md) | [4,060](/filings/0000858877-25-000033.md) | [4,013](/filings/0000858877-25-000171.md) | [4,005](/filings/0000858877-26-000021.md) | [4,002](/filings/0000858877-26-000078.md) | [3,993](/filings/0000858877-25-000171.md) | [3,984](/filings/0000858877-26-000021.md) | [3,982](/filings/0000858877-26-000078.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 3,942,586,873 at 2026-08-27, from the cover of the [10-K filed 2026-09-02](/filings/0000858877-26-000132.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.